|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4880935A
(en)
|
1986-07-11 |
1989-11-14 |
Icrf (Patents) Limited |
Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
|
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
|
IL106992A
(en)
|
1988-02-11 |
1994-06-24 |
Bristol Myers Squibb Co |
Acylhydrazone derivatives of anthracycline and methods for their preparation
|
|
EP0368684B2
(en)
|
1988-11-11 |
2004-09-29 |
Medical Research Council |
Cloning immunoglobulin variable domain sequences.
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
CA2109528A1
(en)
|
1991-05-01 |
1992-11-02 |
Gregory A. Prince |
A method for treating infectious respiratory diseases
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
AU705688B2
(en)
|
1995-11-10 |
1999-05-27 |
Cytogen Corporation |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
|
DK0871490T3
(da)
|
1995-12-22 |
2003-07-07 |
Bristol Myers Squibb Co |
Forgrenede hydrazonlinkere
|
|
ATE508733T1
(de)
|
1996-03-04 |
2011-05-15 |
Penn State Res Found |
Materialien und verfahren zur steigerung der zellulären internalisierung
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
CA2277801C
(en)
|
1997-01-16 |
2002-10-15 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
WO1999066903A2
(en)
|
1998-06-24 |
1999-12-29 |
Advanced Inhalation Research, Inc. |
Large porous particles emitted from an inhaler
|
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
US7555503B1
(en)
|
2000-06-30 |
2009-06-30 |
Click Commerce, Inc. |
Method and apparatus for managing updates to a catalog
|
|
TWI312681B
(en)
|
2001-02-01 |
2009-08-01 |
|
Novel physiologically active substance
|
|
PL207087B1
(pl)
|
2001-04-26 |
2010-10-29 |
Biogen |
Przeciwciało, które wiąże się swoiście z białkiem Cripto, zawierająca je kompozycja farmaceutyczna i zastosowanie przeciwciała
|
|
TWI334866B
(en)
|
2002-05-29 |
2010-12-21 |
Mercian Corp |
Novel physiologically active substances
|
|
CA2494536C
(en)
|
2002-07-31 |
2011-10-04 |
Mercian Corporation |
A 12-membered ring macrolide active substance
|
|
JP4459051B2
(ja)
|
2002-07-31 |
2010-04-28 |
メルシャン株式会社 |
新規生理活性物質
|
|
EP2478912B1
(en)
|
2003-11-06 |
2016-08-31 |
Seattle Genetics, Inc. |
Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
|
|
WO2005075681A1
(ja)
|
2004-02-06 |
2005-08-18 |
Eisai R & D Management Co., Ltd. |
抗癌剤に対する癌細胞の感受性を検定する方法
|
|
EP3101034A1
(en)
|
2004-02-12 |
2016-12-07 |
Morphotek, Inc. |
Monoclonal antibodies that specifically bind to folate receptor alpha
|
|
NZ579482A
(en)
|
2004-06-01 |
2011-02-25 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
DK1791565T3
(en)
|
2004-09-23 |
2016-08-01 |
Genentech Inc |
Cysteingensplejsede antibodies and conjugates
|
|
JP4993645B2
(ja)
|
2004-12-01 |
2012-08-08 |
ジェネンテック， インコーポレイテッド |
抗体薬剤結合体および方法
|
|
EP1928912A4
(en)
|
2005-09-07 |
2010-02-24 |
Medimmune Inc |
EPH ANTI-RECEPTOR ANTIBODIES CONJUGATED TO TOXINS
|
|
JPWO2007043621A1
(ja)
|
2005-10-13 |
2009-04-16 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
プラジエノライドｂ及びプラジエノライドｄの全合成方法
|
|
EP2053393A1
(en)
|
2006-08-02 |
2009-04-29 |
Eisai R&D Management Co., Ltd. |
Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound
|
|
BRPI0717638A2
(pt)
|
2006-10-27 |
2013-11-12 |
Genentech Inc |
Anticorpors e imunoconjugados e usos para os mesmos
|
|
US7790887B2
(en)
|
2007-01-29 |
2010-09-07 |
Eisai R&D Management Co., Ltd. |
Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same
|
|
WO2008111464A1
(ja)
|
2007-03-05 |
2008-09-18 |
Eisai R & D Management Co., Ltd. |
スプライシング異常を指標とする抗ガン剤の作用検定方法
|
|
WO2009008492A1
(ja)
|
2007-07-06 |
2009-01-15 |
Eisai R & D Management Co., Ltd. |
マクロライド系化合物の製造方法およびその製造中間体
|
|
US8653283B2
(en)
|
2009-04-17 |
2014-02-18 |
The Regents Of The University Of California |
Anticancer agents
|
|
JPWO2011074621A1
(ja)
|
2009-12-18 |
2013-04-25 |
株式会社医学生物学研究所 |
メソセリン（ｍｓｌｎ）に対する抗体及びその用途
|
|
US9056910B2
(en)
|
2012-05-01 |
2015-06-16 |
Genentech, Inc. |
Anti-PMEL17 antibodies and immunoconjugates
|
|
HK1203971A1
(en)
|
2012-05-15 |
2015-11-06 |
Bristol-Myers Squibb Company |
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
|
|
CN104640572B
(zh)
|
2012-05-15 |
2018-04-27 |
索伦托医疗有限公司 |
药物偶联物，偶联方法，及其用途
|
|
US20140069822A1
(en)
|
2012-09-10 |
2014-03-13 |
Antec Leyden B.V. |
Electrochemical reduction of disulfide bonds in proteinaceous substances and electrochemical cell for carrying out such reduction
|
|
US9155357B2
(en)
|
2012-09-11 |
2015-10-13 |
Nike, Inc. |
Automated strobel printing
|
|
CN105121421B
(zh)
*
|
2012-11-05 |
2020-10-02 |
辉瑞公司 |
司普力西欧他汀类似物
|
|
US20140275010A1
(en)
|
2013-03-12 |
2014-09-18 |
Guo Zhu Zheng |
Quaternary salts
|
|
US9498532B2
(en)
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
|
CN105517577A
(zh)
|
2013-06-21 |
2016-04-20 |
先天制药公司 |
多肽的酶促偶联
|
|
WO2015015448A2
(en)
|
2013-07-31 |
2015-02-05 |
Rinat Neuroscience Corp. |
Engineered polypeptide conjugates
|
|
CA2919790C
(en)
|
2013-08-02 |
2018-06-19 |
Pfizer Inc. |
Anti-cxcr4 antibodies and antibody-drug conjugates
|
|
CA2924398A1
(en)
|
2013-11-05 |
2015-05-14 |
Immunomedics, Inc. |
Humanized anti-ceacam5 antibody and uses thereof
|
|
IL310627B2
(en)
|
2014-01-31 |
2026-04-01 |
Daiichi Sankyo Co Ltd |
Anti-HER2 antibody-drug conjugates, compositions containing them and uses thereof
|
|
PT3134127T
(pt)
|
2014-04-25 |
2020-04-09 |
Rinat Neuroscience Corp |
Conjugados de anticorpo-fármaco com alta carga de fármaco
|
|
LT3143016T
(lt)
|
2014-05-15 |
2019-06-10 |
Eisai R&D Management Co., Ltd. |
Pladienolido piridino junginiai ir panaudojimo būdai
|
|
JP6349171B2
(ja)
|
2014-07-07 |
2018-06-27 |
ローム株式会社 |
ノイズ除去回路、タイミングコントローラ、ディスプレイ装置、電子機器、ソースドライバの制御方法
|
|
RU2715038C2
(ru)
|
2014-07-11 |
2020-02-21 |
Дженентек, Инк. |
Антитела анти-pd-l1 и способы их диагностического применения
|
|
PL3185908T3
(pl)
|
2014-08-28 |
2020-09-07 |
Pfizer Inc. |
Łączniki modulujące stabilność do stosowania z koniugatami przeciwciało-lek
|
|
UY36519A
(es)
|
2015-01-16 |
2016-08-31 |
Hope City |
Anticuerpos de penetración celular
|
|
TWI703159B
(zh)
|
2015-04-13 |
2020-09-01 |
美商輝瑞股份有限公司 |
Bcma特異性治療性抗體及其用途
|
|
WO2017011803A1
(en)
*
|
2015-07-16 |
2017-01-19 |
Cellerant Therapeutics, Inc. |
Cysteine-substituted immunoglobulins
|
|
JP6876680B2
(ja)
|
2015-09-01 |
2021-05-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ネオモルフィックｓｆ３ｂ１変異体に関連するスプライスバリアント
|
|
BR112018009995B1
(pt)
|
2015-11-18 |
2024-04-30 |
Eisai R&D Management Co., Ltd |
Forma cristalina, composição farmacêutica, e, uso da forma cristalina
|
|
TWI727380B
(zh)
|
2015-11-30 |
2021-05-11 |
美商輝瑞股份有限公司 |
位點專一性ｈｅｒ２抗體藥物共軛體
|
|
CN109219618B
(zh)
|
2016-01-21 |
2022-08-09 |
辉瑞大药厂 |
针对表皮生长因子受体变体iii和cd3的单特异性和双特异性抗体及其用途
|
|
PE20231050A1
(es)
|
2016-03-02 |
2023-07-11 |
Eisai Randd Man Co Ltd |
Conjugados de anticuerpo y farmaco basados en eribulina y metodos para su uso
|
|
CN105669800B
(zh)
|
2016-03-03 |
2017-12-15 |
湖南省农产品加工研究所 |
一种从柑橘中联合提取精油、果胶、橙皮苷、辛弗林和柠檬苦素的方法
|
|
EP3464379B1
(en)
|
2016-06-06 |
2023-09-27 |
Abzena (UK) Limited |
Antibodies, uses thereof and conjugates thereof
|
|
KR20220150408A
(ko)
|
2016-11-14 |
2022-11-10 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
|
WO2018185618A1
(en)
|
2017-04-03 |
2018-10-11 |
Novartis Ag |
Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment
|
|
GB201711068D0
(en)
|
2017-07-10 |
2017-08-23 |
Crescendo Biologics Ltd |
Therapeutic molecules binding PSMA
|
|
EP3694887A4
(en)
|
2017-10-13 |
2022-02-23 |
A & G Pharmaceutical, Inc. |
MONOCLONAL ANTIBODIES AND CONJUGATES TO PROSTAGLANDIN F2 RECEPTOR INHIBITOR AND USES THEREOF
|
|
SG11202009906TA
(en)
|
2018-04-09 |
2020-11-27 |
Eisai R&D Man Co Ltd |
Pladienolide compounds and their use
|
|
CA3096424A1
(en)
|
2018-04-12 |
2019-10-17 |
Eisai R&D Management Co., Ltd. |
Pladienolide derivatives as spliceosome targeting agents for treating cancer
|
|
CN119405832A
(zh)
|
2018-06-01 |
2025-02-11 |
卫材R&D管理有限公司 |
剪接调节抗体-药物缀合物及其使用方法
|
|
EP3801523B1
(en)
|
2018-06-01 |
2024-09-11 |
Eisai R&D Management Co., Ltd. |
Splicing modulators
|
|
SG11202102419VA
(en)
|
2018-12-13 |
2021-04-29 |
Eisai R&D Man Co Ltd |
Herboxidiene splicing modulator antibody-drug conjugates and methods of use
|
|
WO2021090062A1
(en)
|
2019-11-07 |
2021-05-14 |
Eisai R&D Management Co., Ltd. |
Anti-mesothelin eribulin antibody-drug conjugates and methods of use
|
|
JP7821733B2
(ja)
|
2020-01-22 |
2026-02-27 |
上海森輝医薬有限公司 |
エリブリン誘導体の薬物複合体、その調製方法及びその医薬的応用
|
|
AU2021284401A1
(en)
|
2020-06-05 |
2023-01-05 |
Eisai R&D Management Co., Ltd. |
Anti-BCMA antibody-drug conjugates and methods of use
|